Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2008 1
2009 2
2011 3
2012 1
2015 4
2016 1
2017 5
2018 1
2019 3
2020 3
2021 5
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth.
Han A, Mukha D, Chua V, Purwin TJ, Tiago M, Modasia B, Baqai U, Aumiller JL, Bechtel N, Hunter E, Danielson M, Terai M, Wedegaertner PB, Sato T, Landreville S, Davies MA, Kurtenbach S, Harbour JW, Schug ZT, Aplin AE. Han A, et al. Among authors: terai m. Cancers (Basel). 2023 Jun 30;15(13):3451. doi: 10.3390/cancers15133451. Cancers (Basel). 2023. PMID: 37444561 Free PMC article.
Individualised neoantigen cancer vaccine therapy.
Terai M, Sato T. Terai M, et al. Lancet. 2024 Feb 17;403(10427):590-591. doi: 10.1016/S0140-6736(23)02463-7. Epub 2024 Jan 18. Lancet. 2024. PMID: 38246193 No abstract available.
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma.
Tanaka R, Terai M, Londin E, Sato T. Tanaka R, et al. Among authors: terai m. Cancers (Basel). 2021 Oct 30;13(21):5457. doi: 10.3390/cancers13215457. Cancers (Basel). 2021. PMID: 34771620 Free PMC article. Review.
Improved Uveal Melanoma Copy Number Subtypes Including an Ultra-High-Risk Group.
Lalonde E, Ewens K, Richards-Yutz J, Ebrahimzedeh J, Terai M, Gonsalves CF, Sato T, Shields CL, Ganguly A. Lalonde E, et al. Among authors: terai m. Ophthalmol Sci. 2022 Jan 30;2(2):100121. doi: 10.1016/j.xops.2022.100121. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249692 Free PMC article.
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma.
Terai M, Shimada A, Chervoneva I, Hulse L, Danielson M, Swensen J, Orloff M, Wedegaertner PB, Benovic JL, Aplin AE, Sato T. Terai M, et al. Cancers (Basel). 2021 Nov 17;13(22):5749. doi: 10.3390/cancers13225749. Cancers (Basel). 2021. PMID: 34830903 Free PMC article.
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma.
Ohara M, Saito K, Kageyama K, Terai M, Cheng H, Aplin AE, Sato T. Ohara M, et al. Among authors: terai m. Cancers (Basel). 2021 Mar 4;13(5):1104. doi: 10.3390/cancers13051104. Cancers (Basel). 2021. PMID: 33806615 Free PMC article.
Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma.
Lapadula D, Farias E, Randolph CE, Purwin TJ, McGrath D, Charpentier TH, Zhang L, Wu S, Terai M, Sato T, Tall GG, Zhou N, Wedegaertner PB, Aplin AE, Aguirre-Ghiso J, Benovic JL. Lapadula D, et al. Among authors: terai m. Mol Cancer Res. 2019 Apr;17(4):963-973. doi: 10.1158/1541-7786.MCR-18-0574. Epub 2018 Dec 19. Mol Cancer Res. 2019. PMID: 30567972 Free PMC article.
32 results